VISTAGEN THERAPEUTICS INC (VTGN) Top Institutional Shareholders

VISTAGEN THERAPEUTICS INC (VTGN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $7.75M in VTGN holdings during the latest filing period.

Orbimed Advisors Llc is currently the largest disclosed institutional shareholder of VTGN tracked by InsiderSet, reporting ownership valued at approximately $1.75M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $2.11M, representing an estimated gain of +20.73% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 80% of the total disclosed VTGN value among the investors covered in this analysis. Major shareholders include Orbimed Advisors Llc, Tcg Crossover Management, Llc, Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in VISTAGEN THERAPEUTICS INC (VTGN).

This page ranks the largest institutional VTGN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

55

Total Reported Value

$7.75M

Largest Holder

Orbimed Advisors Llc

Largest Position

$1.75M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

70

Funds Exiting Positions

0

Page 1 of 2
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Orbimed Advisors Llc0.04%3,060,000$1,748,790$2,111,400+$362,610+20.73%
Tcg Crossover Management, Llc0.04%2,676,580$1,529,665$1,846,840+$317,175+20.73%
Vanguard Capital Management Llc0.00%1,574,200$900,442$1,086,198+$185,756+20.63%
Adar1 Capital Management, Llc0.03%751,141$429,277$518,287+$89,010+20.73%
Ikarian Capital, Llc0.04%519,077$296,654$358,163+$61,509+20.73%
Two Sigma Investments, Lp0.00%469,619$268,387$324,037+$55,650+20.74%
Geode Capital Management, Llc0.00%453,391$259,170$312,840+$53,670+20.71%
Blackrock, Inc.0.00%448,507$256,322$309,470+$53,148+20.73%
Millennium Management Llc0.00%430,404$245,976$296,979+$51,003+20.73%
Luminus Management Llc0.14%396,053$226,344$273,277+$46,933+20.74%
Renaissance Technologies LLCJim Simons0.00%291,300$166,478$200,997+$34,519+20.73%
Advisorshares Investments Llc0.03%277,110$158,368$191,206+$32,838+20.74%
Jane Street Group, Llc0.00%272,811$155,912$188,240+$32,328+20.73%
Vanguard Fiduciary Trust Co0.00%217,700$124,524$150,213+$25,689+20.63%
Verdad Advisers, Lp0.12%184,938$105,692$127,607+$21,915+20.73%
Xtx Topco Ltd0.00%152,849$87,353$105,466+$18,113+20.74%
Shay Capital Llc0.01%144,452$82,554$99,672+$17,118+20.74%
Susquehanna International Group, Llp0.00%142,607$81,500$98,399+$16,899+20.73%
Boothbay Fund Management, Llc0.00%134,571$76,907$92,854+$15,947+20.74%
State Street Corp0.00%121,114$69,217$83,569+$14,352+20.73%
Tudor Investment Corp Et Al0.00%106,172$60,677$73,259+$12,582+20.74%
Diadema Partners Lp0.02%105,428$60,252$72,745+$12,493+20.74%
Stempoint Capital Lp0.01%616,749$58,187$425,557+$367,370+631.36%
Simplex Trading, Llc0.00%89,649$51,279$61,858+$10,579+20.63%
Ubs Group Ag0.00%78,736$45,037$54,328+$9,291+20.63%
Northern Trust Corp0.00%72,655$41,522$50,132+$8,610+20.74%
Prudential Financial Inc0.00%53,100$30,347$36,639+$6,292+20.73%
Persistent Asset Partners Ltd0.01%26,612$15,209$18,362+$3,153+20.73%
Schonfeld Strategic Advisors Llc0.00%26,589$15,194$18,346+$3,152+20.75%
Kestra Advisory Services, Llc0.00%26,000$14,859$17,940+$3,081+20.73%
Hightower Advisors, Llc0.00%20,628$11,789$14,233+$2,444+20.73%
Group One Trading Llc0.00%19,875$11,359$13,714+$2,355+20.73%
Truvestments Capital Llc0.00%16,992$9,711$11,724+$2,013+20.73%
Two Sigma Securities, Llc0.00%16,495$9,427$11,382+$1,955+20.73%
Stonex Group Inc.0.00%15,198$8,686$10,487+$1,801+20.73%
Raymond James Financial Inc0.00%14,884$8,507$10,270+$1,763+20.72%
Caption Management, Llc0.00%14,664$8,380$10,118+$1,738+20.74%
Vanguard Global Advisers, Llc0.00%10,809$6,183$7,458+$1,275+20.62%
Performa Ltd (Us), Llc0.00%7,500$4,286$5,175+$889+20.74%
Osaic Holdings, Inc.0.00%4,133$2,357$2,852+$495+20.99%
Royal Bank Of Canada0.00%2,127$1,000$1,468+$468+46.76%
Tower Research Capital Llc (Trc)0.00%1,572$898$1,085+$187+20.79%
Annis Gardner Whiting Capital Advisors, Llc0.00%600$343$414+$71+20.70%
Acadian Asset Management Llc0.00%589,663$336$406,867+$406,531+120991.51%
Cwm, Llc0.00%582$333$402+$69+20.59%
Mai Capital Management0.00%526$301$363+$62+20.58%
Sbi Securities Co., Ltd.0.00%288$165$199+$34+20.44%
Jones Financial Companies Lllp0.00%114$65$79+$14+21.02%
Gsa Capital Partners Llp0.00%49,842$28$34,391+$34,363+122724.93%
Fairman Group, Llc0.00%29$17$20+$3+17.71%

Frequently asked questions about VTGN

  • Who owns the most VTGN stock?

    The largest holders of VTGN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VISTAGEN THERAPEUTICS INC (VTGN).

  • Is VTGN widely held by superinvestors?

    Many widely followed stocks like VTGN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VTGN is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.